JP Morgan Chase
BSPM

JP Morgan Chase’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

JP Morgan Chase’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-29,282
Closed -$68K – 5501
2017
Q1 		$68K Sell
29,282
-13,195
-31% -$34.6K ﹤0.01% 4446
2016
Q4 		$124K Buy
+42,477
New +$145K ﹤0.01% 4339

Other funds holding BSPM

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's BSPM Position: Q2 2017 in Review

JP Morgan Chase sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q2 2017, closing a stake of 29,282 shares — an estimated $68K sold.

JP Morgan Chase first reported a position in BSPM in Q4 2016 and held it in 2 quarters. The position peaked at $124K in Q4 2016. 5 funds tracked by Wall St. Rank hold BSPM as of Q2 2017.

  • JP Morgan Chase reported no remaining Biostar Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • JP Morgan Chase sold 29,282 Biostar Pharmaceuticals, Inc. shares in Q2 2017, an estimated $68K.
  • JP Morgan Chase first reported a position in Biostar Pharmaceuticals, Inc. in Q4 2016 and held it in 2 quarters.
  • JP Morgan Chase's Biostar Pharmaceuticals, Inc. position peaked at $124K in Q4 2016.
  • 5 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q2 2017.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.